Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

Original Article

D. Rosmarin, T. Passeron, A.G. Pandya, P. Grimes, J.E. Harris, S.R. Desai, M. Lebwohl, M. Ruer-Mulard, J. Seneschal, A. Wolkerstorfer, D. Kornacki, K. Sun, K. Butler, and K. Ezzedine

N Engl J Med 2022;387:1445-1455

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
10/19/2022
Course expires: 
10/20/2024
Take course

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Take course